trans-Platinum Compounds in Cancer Therapy: A Largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs
- 1 January 1999
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Platinum(II) complexes containing iminoethers: a trans platinum antitumour agentChemico-Biological Interactions, 1995
- DNA Adducts of cis-Diamminedichloroplatinum(II) and Its Trans Isomer Inhibit RNA Polymerase II Differentially in VivoBiochemistry, 1995
- Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateEuropean Journal Of Cancer, 1993
- Sequence-dependent distortions induced in DNA by monofunctional platinum(II) bindingBiochemistry, 1992
- DNA binding properties of [Pt(NH3)(C6H11NH2)Cl2], a metabolite of an orally active platinum anticancer drugJournal of the American Chemical Society, 1992
- Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum (II). Immunochemical analysisEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexesChemico-Biological Interactions, 1989
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- Crystal and molecular structure of three isomers of dichlorodiamminedihydroxoplatinum(IV): cis-trans isomerization on recrystallization from waterInorganic Chemistry, 1983
- The Stereochemistry of Complex Inorganic Compounds. X. The Stereoisomers of Dichlorobis-(ethylenediamine)-platinum (IV) Chloride1Journal of the American Chemical Society, 1950